Post-trial provisions
Unblinding after a randomized blinded trial of spironolactone or doxycycline to treat acne in women.
Barbieri JS, Ellenberg SS, Tierney A, Dattilo J, Mason AC, Mason JB, Papadopoulos Mbe M, Baez S, Margolis DJ
Journal of Investigative DermatologyIn the feed 24 Sep 2026, published online 24 Sep 2026, issue 2026 Sep 24, added to PubMed 24 Sep 2026
Topics: Acne
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42785471 · DOI 10.1016/j.jid.2026.09.849